Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million; Shares Gain 2%
Sun Pharmaceuticals announced that it will acquire Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology
